Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
MISTMilestone Pharmaceuticals	$247.10m	n/a	n/a
RNAAtrium Therapeutics	$246.62m	n/a	n/a
VYGRVoyager Therapeutics	$246.15m	n/a	n/a
THRDThird Harmonic Bio	$242.79m	n/a	n/a
IKTInhibikase Therapeutics	$241.62m	n/a	n/a
SLGLSol Gel Technologies	$239.73m	n/a	n/a
OABIOmniAB	$237.44m	n/a	n/a
NVCTNuvectis Pharma	$235.78m	n/a	n/a
CDXSCodexis	$235.35m	n/a	n/a
CAMPCAMP4 Therapeutics	$233.12m	n/a	n/a
QSIQuantum-Si	$231.51m	n/a	n/a
KROSKeros Therapeutics	$230.10m	4.91	n/a
SLRNAcelyrin	$227.15m	n/a	n/a
MACKMerrimack Pharmaceuticals	$223.75m	n/a	n/a
MGNXMacroGenics	$219.92m	n/a	n/a
ALXOALX Oncology Holdings	$219.79m	n/a	n/a
CRGXCARGO Therapeutics	$219.57m	n/a	n/a
PRQRProQR Therapeutics NV	$214.34m	n/a	n/a
PRLDPrelude Therapeutics	$214.34m	n/a	n/a
CRBUCaribou Biosciences	$212.60m	n/a	n/a